Showing results (631-640 of 800) with videos related to
Sort By:
Pageof 80
The Annals of Thoracic Surgery|May 24, 2015
Bilateral Internal Mammary Artery Use for Coronary Artery Bypass Grafting Remains Underutilized: A Propensity-Matched Multi-Institution AnalysisDamien J LaPar, Ivan K Crosby, Jeffrey B Rich, et al.The Annals of Thoracic Surgery|April 22, 2009
Model for end-stage liver disease predicts mortality for tricuspid valve surgeryGorav Ailawadi, Damien J Lapar, Brian R Swenson, et al.Journal of Medical Economics|May 26, 2022
Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settingsAndrew Blauvelt, Nianwen Shi, Mwangi J Murage, et al.The Annals of Thoracic Surgery|August 14, 2021
Progression to Transplant Under the New Heart Allocation System: The Society of Thoracic Surgeons Intermacs DatabaseLeora T Yarboro, J Hunter Mehaffey, Ryan Cantor, et al.Osteoarthritis and Cartilage|March 16, 2021
Novel high-intensive cholesterol-lowering therapies do not ameliorate knee OA development in humanized dyslipidemic miceY van Gemert, A E Kozijn, M G Pouwer, et al.The Annals of Thoracic Surgery|February 24, 2009
Do you need to clamp a patent left internal thoracic artery-left anterior descending graft in reoperative cardiac surgery?Robert L Smith, Peter I Ellman, Peter W Thompson, et al.Lung Cancer (Amsterdam, Netherlands)|December 19, 1998
Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B studyS L Graziano, J A Kern, J E Herndon, et al.International Journal of Cancer|July 11, 2006
COX-2 upregulation in thymomas and thymic carcinomasRalf J Rieker, Stefan Joos, Gunhild Mechtersheimer, et al.The Annals of Thoracic Surgery|August 5, 2014
Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costsDamien J LaPar, Alan M Speir, Ivan K Crosby, et al.Clinical Pharmacology in Drug Development|April 30, 2016
PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues - A population pharmacokinetic/pharmacodynamic analysis of rucaparibDiane D Wang, Chunze Li, Wan Sun, et al.Pageof 80